TATA ELXSI LTD. - 500408 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2022 And Dividend, If Any
TATA ELXSI LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2022 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2022, and recommend dividend for the year 2021-22, if any TATA ELXSI LTD. - 500408 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015
Multibagger stock: Why Tata Elxsi share price is skyrocketing explained
Multibagger stock: Tata group company has a diversified portfolio where it has an ambitious driver-less car project in auto segment
Tata Elxsi gains 5%, hits record high in a weak market
In the past three months, the stock has outperformed the market by surging 45 per cent as the company delivered strong and consistent growth in December quarter. TATA ELXSI LTD. - 500408 - Closure of Trading Window
This is to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Company''s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company by its Designated Persons will remain closed from March 25, 2022. TATA ELXSI LTD. - 500408 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meeting TATA ELXSI LTD. - 500408 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 TATA ELXSI LTD. - 500408 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Tata Elxsi has unveiled TEngage, a digital health platform designed for omnichannel care at the HIMSS 2022 Global Health Conference & Exhibition in Orlando, Florida. TATA ELXSI LTD. - 500408 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015
Neutral Tata Elxsi; target of Rs 6755: Choice Equity Broking
Choice Equity Broking recommended Neutral rating on Tata Elxsi with a target price of Rs 6755 in its research report dated March 16, 2022.